DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Olainfarm
Olainfarm
Effects of Supplementary Protection Mechanisms for Pharmaceutical Products
List of Tuberculosis Pharmaceutical Products Classified According to the Global Fund Quality Assurance Policy
Points of Excellence
ESG Report 2018
PHARMACEUTICALS + Biovian Oy Jemedic AB Bayer Oy + Shetland Bergen Helse Bergen HF, Haukeland 3
Copyright Notice
Audited Country Address Product Type Audit Date Audit Format
Analysis of the Global Fund Financed Market for TB Medicines: Competitive Landscape, Market Shares, Product Volumes and Product Variety
Webinar Presentation H1 2021
Olainfarm III 2017 Consolidated FS ENG
Olainfarm IV 2018 Consolidated FS ENG
Consolidated and Parent Company's Annual Report
JSC Olainfarm Webinar Presentation Q4 2020
Report on Structured Interviews with Logistics Service Providers and Shippers
Joint Stock Company Olainfarm Consolidated and the Group's Parent Company's Annual Report
Baltic & Nordic Roadshow Presentation
JSC Olainfarm ENVIRONMENTAL, SOCIAL and GOVERNANCE REPORT 2017
Internal Audit Team, Coordinating Their Activities and Thus Achieving Significantly Greater Operational Efficiency
Top View
Prezentace Aplikace Powerpoint
Joint Stock Company/ Limited Liability Company
Audit Reports Available/Updated May 2021
Industry in LATVIA Latvia in Facts
23 Baltic Chemistry Olympiad's Newspaper
Webinar Presentation
Meet, Network & Learn FDF, Co-Located with Cphi Worldwide, Is
List of the Medicines Recommended for Registration by N 12-1/16 Meeting Decision of the Pharmacological Council of Moh of RA Dated on December 09, 2016
Joint Stock Company Olainfarm (Unified Registration Number 40003007246)
Four Years and Counting Slow Scale-Up of Newer Mdr-Tb Drugs Issue Issue Brief Covers Less Than 5% in Need
Gen 23-3-18 Pgs.1-16.Indd
Phenazepam Pre-Review Report Agenda Item 5.8
Unaudited Interim Condensed Consolidated Financial Statements for the 3 Months Period Ended 31 March 2020
Olainfarm Ll 2019 Consolidated FS ENG
Joint Stock Company/ Limited Liability Company
Olainfarm 2016 Consolidated and Parent FS ENG
2020Annual Report
Clonazepam Procedure No.: PSUSA/00000812/201506
High Court Judgment Template
Dr-Tb Drugs Under the Microscope Issue Issue Brief 6Th Edition
P-Aminosalicylic Acid 5.52 G Powder for Oral Solution (Olainfarm JSC
List Item List of Participants: Towards EU Accession: Serbia's Regulatory
Copyright Notice
CEO Meets Investor
EV/EBITDA Ones That Have Proven Their Stability Through the Recent Market Downturn Historical US High Yield Debt Effective Yield
Nitrofurantoin / Nifurtoinol Regulatory Outcome
EY2010 Journalist Award LATVIA Winner Print/Online
Tuberculosis Medicines Technology and Market Landscape
Pharmaceutical Companies M.J
Unaudited Interim Condensed Consolidated Financial Statements for the 3 Months Period Ended 31 March 2018
Company Presentation
Olainfarm 2018 Consolidated and Parent AR ENG
Copyright Notice
Pharmacokinetics, Antitumor Activity, and Safety of ODM-201 in Patients
Guide to Listed Securities 2003 Riga Stock Exchange Latvia
Company Name Country Stand Number 3P Biopharmaceuticals. SPAIN 8G83 5M Biotech India INDIA 10D101 Aaipharma/ Cambridge Major Labs UNITED STATES 5D60 Aarti Drugs Ltd
Joint Stock Company Olainfarm (Unified Registration Number 40003007246)
JSC Olainfarm
Latvia's Biopharma Industry – Competitive Location of Regional
Joint Stock Company/ Limited Liability Company
Liaa Kjiimija Iistaa
DDF Summit Berlin 2018
The Marketing of Medications in Post-Soviet Latvia
Jsc Olainfarm
Olainfarm IV 2017 Consolidated FS ENG
JSC Olainfarm for Five Years